Call Options

9 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$0.71 - $1.65 $8,165 - $18,975
11,500 New
11,500 $14,000
Q4 2022

Feb 14, 2023

BUY
$2.98 - $4.17 $12,218 - $17,097
4,100 Added 20.71%
23,900 $80,000
Q3 2022

Nov 14, 2022

BUY
$2.61 - $3.98 $51,678 - $78,804
19,800 New
19,800 $78,000
Q1 2022

May 16, 2022

SELL
$3.59 - $4.64 $140,010 - $180,960
-39,000 Reduced 28.12%
99,700 $446,000
Q4 2021

Feb 14, 2022

BUY
$3.89 - $6.71 $381,998 - $658,922
98,200 Added 242.47%
138,700 $540,000
Q3 2021

Nov 15, 2021

BUY
$3.54 - $5.13 $41,064 - $59,508
11,600 Added 40.14%
40,500 $182,000
Q2 2021

Aug 11, 2021

SELL
$3.41 - $5.9 $30,008 - $51,920
-8,800 Reduced 23.34%
28,900 $116,000
Q1 2021

May 17, 2021

BUY
$5.06 - $8.0 $133,584 - $211,200
26,400 Added 233.63%
37,700 $206,000
Q3 2020

Nov 16, 2020

BUY
$5.86 - $12.04 $66,218 - $136,052
11,300 New
11,300 $78,000

Others Institutions Holding BMRA

About BIOMERICA INC


  • Ticker BMRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 13,427,700
  • Market Cap $3.76M
  • Description
  • Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various disea...
More about BMRA
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.